Koyfin Home > Directory > Health Care > ANI Pharma Inc > Long-Term Debt / Capital

ANI Pharma Inc Long-Term Debt / Capital Chart (ANIP)

ANI Pharma Inc annual/quarterly Long-Term Debt / Capital from 2014 to 2020.
  • ANI Pharma Inc Long-Term Debt / Capital for the quarter ending June 06, 2020 was $49m a 63.43% increase of 31m year over year
  • ANI Pharma Inc Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $49m a 63.43% increase of 31m year over year
  • ANI Pharma Inc Annual Long-Term Debt / Capital for 2019 was $45m a 60.43% increase of 27m from 2018
  • ANI Pharma Inc Annual Long-Term Debt / Capital for 2018 was $18m a -195.80% decrease of -35m from 2017
  • ANI Pharma Inc Annual Long-Term Debt / Capital for 2017 was $53m a 21.09% increase of 11m from 2016
Other Ratios Metrics:
  • ANI Pharma Inc Total Debt / Capital for the quarter ending December 12, 2018 was $48m a -10.11% decrease of -5m year over year
  • ANI Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -404.03% decrease of -2m year over year
  • ANI Pharma Inc Total Debt / Equity for the quarter ending December 12, 2018 was $93m a -21.52% decrease of -20m year over year
View Chart On Koyfin

Quarterly ANIP Long-Term Debt / Capital Data

06/2020$49m
03/2020$49m
12/2019$45m
09/2019$18m
06/2019$18m
03/2019$18m
12/2018$18m
09/2018$50m
06/2018$51m
03/2018$52m

Annual ANIP Long-Term Debt / Capital Data

2019$45m
2018$18m
2017$53m
2016$42m
2015$41m
2014$43m
2011$173m